InvestorsHub Logo
Followers 21
Posts 1744
Boards Moderated 0
Alias Born 03/12/2013

Re: None

Tuesday, 07/29/2014 2:59:35 PM

Tuesday, July 29, 2014 2:59:35 PM

Post# of 158400
What the price tag for D cell vax worth?
Share
Tools

Comment
Print
Contact Author
Reprint

Quark Pharmaceuticals' gene-silencing treatment for kidney transplant complications missed its primary endpoint in a Phase II trial, possibly jeopardizing a deal with Novartis ($NVS) worth up to $680 million.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.